![Michael Engsig](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Engsig
Directeur Général chez NYKODE THERAPEUTICS
Fortune : 23 817 $ au 31/05/2024
Postes actifs de Michael Engsig
Sociétés | Poste | Début | Fin |
---|---|---|---|
NYKODE THERAPEUTICS | Directeur Général | 01/03/2007 | - |
Investor Relations Contact | 01/03/2007 | - | |
FLUOGUIDE A/S | Directeur/Membre du Conseil | 01/01/2023 | - |
Historique de carrière de Michael Engsig
Anciens postes connus de Michael Engsig
Sociétés | Poste | Début | Fin |
---|---|---|---|
KLIFO A/S
![]() KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - | - |
Takeda A/S
![]() Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Michael Engsig
Technical University of Denmark | Graduate Degree |
Statistiques
Internationale
Danemark | 5 |
Norvège | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Chief Executive Officer | 1 |
Investor Relations Contact | 1 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
NYKODE THERAPEUTICS | Health Technology |
FLUOGUIDE A/S | Health Technology |
Entreprise privées | 2 |
---|---|
Takeda A/S
![]() Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
KLIFO A/S
![]() KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Commercial Services |
- Bourse
- Insiders
- Michael Engsig
- Expérience